Nanoscope
Samarendra Mohanty, currently serving as the Chief Scientific Officer at Nanoscope Therapeutics Inc. and NanoScope Technologies, LLC, is leading the clinical translation of technologies developed in the NanoScope laboratory. Their work focuses on early cancer detection, vision restoration in RP/AMD patients, as well as the development of technologies for pain and cancer control. Mohanty holds a Ph.D. from the Indian Institute of Science (IISc) and an M.Tech from the Indian Institute of Technology, Delhi.
This person is not in the org chart
This person is not in any offices
Nanoscope
Nanoscope Technologies was founded in 2009 with the objective to develop new methods and devices for scientific, industrial, and biomedical applications. Nanoscope has developed a range of biomedical technologies which include diagnostics and therapeutic devices and molecules.